December 7, 2020
Teresa Sanchez, Ph.D., Assistant Professor of Pathology and Laboratory Medicine, was featured twice on the website of the influential North American Vascular Biology Organization (NAVBO) during the month of November, 2020. Teresa Sanchez, PhDAssistant Professor of Pathology and Laboratory Medicine The Members' Labs page of the website highlighted her primary research, which investigates the molecular mechanisms governing endothelial dysfunction in various pathological conditions such as cerebrovascular diseases (e.g., ischemic stroke, subarachnoid hemorrhage) and sepsis. The NAVBO Education...
November 22, 2020
Common symptoms of the genetic disorder neurofibromatosis type 1 (NF1), including skeletal fragility and the loss of bone mass, may be treatable with an existing anti-cancer drug, according to a study from researchers at Weill Cornell Medicine. The findings reveal the potential for an expanding array of therapeutic options for patients who have this difficult-to-treat condition.Matthew B. Greenblatt, MD, PhDAssociate Professor of Pathology and Laboratory MedicineThe study, published Nov. 11 in Nature Communications, uncovered a signaling pathway in bone-making cells that helps drive the...
November 22, 2020
Molecular changes in cells called fibroblasts, which help provide support for tissues throughout the body, may explain why one type of colon cancer doesn’t respond to therapy, according to a team of researchers from Weill Cornell Medicine. Targeting these cells may be a way to make treatment more effective.Jorge Moscat, PhDProfessor of Pathology and Laboratory MedicineIn a study published Nov. 17 in Developmental Cell the investigators examined cells called fibroblasts in CMS4, the most aggressive and difficult-to-treat form of colorectal cancer, to determine how these cancer-associated cells...
November 16, 2020
Congratulations to Dr. Massimo Loda for receiving the Meritorious Achievement Award from the Society for Basic Urologic Research (SBUR).
October 6, 2020
Dr. Anna S. Nam, an assistant professor of pathology and laboratory medicine at Weill Cornell Medicine...
September 9, 2020
We are pleased to announce that several faculty (Drs. Borczuk, Mosquera, Imielinski and Ince) in the Department have received grants from the New York Genome Center, to address the role of ethnicity in several major cancer types.The award-winning cancer research projects include:
July 28, 2020
Message from the Dean of WCM:Congratulations to our partner NewYork-Presbyterian on its U.S. News & World Report “Best Hospitals” ranking as #4! Please see the below announcement from Dr. Steven Corwin and Dr. Laura Forese on this wonderful accomplishment.This national recognition highlights our academic medical center’s reputation as a leader in healthcare. Together we will continue to offer the best, most compassionate care in New York City and beyond.Sincerely,Augustine M.K. Choi, M.D.Stephen and Suzanne Weiss DeanWeill Cornell MedicineProvost for Medical AffairsCornell University
July 22, 2020
A code discovered in DNA packaging proteins enables the rapid expression of genes needed to fight immediate threats, a finding that may pave the way for new treatments for cancer and inflammatory diseases, according to a study by investigators at Weill Cornell Medicine.A study published in Nature on July 22 found that when a chemical tag composed of a phosphate group is added to H3.3, one of the spool-like histone proteins that condense DNA and control access to genes, the cell’s gene expression machinery can quickly find the genes.Dr. Steven JosefowiczAssistant Professor of Pathology and...
July 2, 2020
Please join us in congratulating Domenick Falcone, PhD on becoming the inaugural Assistant Dean for Foundation Curriculum.
July 2, 2020
We are pleased to announce the appointment of Jessica Tyler, PhD, Professor of Pathology and Laboratory Medicine, as Diversity Champion representing the Department.